diazoxide-resistant focal hyperinsulinism
ORPHA: 792981 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| diazoxide Orphan | Oral suspension, 50mg/mL | FDA Approved, EMA Approved | 6 | 14d |
Classification & Codes
Orphanet Code
ORPHA:79298diazoxide-resistant focal hyperinsulinism
| Orphanet | ORPHA:79298 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO